eHealth, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated December 31, 2025, details a material refinancing transaction and amendments to existing investment agreements by eHealth, Inc. (the "Company"). The report covers the entry into a new asset-based revolving credit facility and the termination of a prior credit agreement on the Closing Date of December 31, 2025.
Key Financial Metrics and Capital Structure
- New Debt Facility: Entered into a new asset-based revolving credit facility with aggregate commitments of up to $125.0 million, with an option to increase by an additional $50.0 million.
- Utilization: The Borrower drew the full $125.0 million on the Closing Date.
- Interest Rates: Borrowings are subject to a Base Rate plus 5.50% or Term SOFR (floored at 2.00%) plus 6.50%.
- Maturity: The facility matures in December 2028.
- Collateral: Secured by a first-priority lien on substantially all assets of the Loan Parties.
- Financial Covenants:
- Maximum Total Leverage Ratio: 2.50:1.00 (through Q3 2026), stepping down to 2.00:1.00 (through Q3 2027), and 1.75:1.00 thereafter.
- Minimum Unrestricted Cash: $45.0 million as of the last day of each calendar month.
- Minimum Lifetime Value to Acquisition Cost Ratio: 1.275:1.00.
Material Changes Versus Prior Period
The Company terminated the "Blue Torch Credit Agreement" (dated February 28, 2022) and used the proceeds from the new facility to repay all outstanding obligations under that agreement. Additionally, the Company amended its 2021 Investment Agreement with H.I.G. Capital (Echelon Health SPV, LP) to explicitly permit the new credit facility and added a liquidity covenant. A breach of this liquidity covenant triggers a 2.00% increase in the paid-in-kind dividend rate for the Series A Preferred Stock.
Guidance, Risks, and Contingencies
The filing does not provide specific revenue or earnings guidance. However, it outlines significant risks and contingencies associated with the new debt structure:
- Covenant Compliance: The Company must strictly adhere to leverage, cash, and valuation covenants. Failure to maintain the minimum unrestricted cash balance of $45.0 million or the leverage ratios could result in a default or an increased dividend rate on preferred stock.
- Prepayment Penalties: Voluntary reductions or terminations of commitments prior to the second anniversary of the Closing Date are subject to prepayment premiums (up to 2.00% or a make-whole premium).
- Restrictive Covenants: The agreement limits the Company's ability to incur additional debt, pay dividends, redeem stock, make restricted payments, or engage in mergers without lender consent.
- Events of Default: Includes payment defaults, covenant breaches, cross-defaults, bankruptcy, and changes of control.
Investor Verification Checklist
- Verify the Company's current unrestricted cash balance to ensure compliance with the $45.0 million minimum covenant.
- Review the latest financial statements to calculate the Total Leverage Ratio and confirm it is below the 2.50:1.00 threshold.
- Assess the impact of the increased dividend rate on Series A Preferred Stock if liquidity covenants are breached.
- Monitor the "Borrowing Base" calculation, which relies on the net present value of future commission streams and is subject to concentration limits and reserves.
- Confirm the status of the $50.0 million accordion feature and the conditions required to exercise it.